Group 1 - The core point of the announcement is that Xi'an International Medical Investment Co., Ltd. will issue shares to specific investors in 2025, ensuring that there will be no financial support or compensation provided to the investors involved in the subscription [1][3][4] - The company guarantees that it will not make any commitments to guarantee returns or provide financial support to investors participating in the subscription [1][3] - The board of directors has approved the proposal for the issuance of shares, which is subject to further approval from the shareholders' meeting and regulatory authorities [1][29][30] Group 2 - The company has conducted an analysis of the potential dilution of immediate returns due to the share issuance and has proposed specific measures to mitigate this risk [4][5][16] - The company plans to raise a maximum of 1,007.54 million yuan through this issuance, with the funds allocated to projects that align with national industrial policies and the company's strategic development [37][8] - The company emphasizes that the implementation of the fundraising projects will enhance its market competitiveness and financial structure, ultimately benefiting shareholders [9][15][16] Group 3 - The company has a strong personnel reserve, with over 25% of its medical staff holding senior technical titles and more than 50% having master's or doctoral degrees [12] - The company has established a solid technical foundation in the healthcare sector, focusing on innovative business models to meet diverse healthcare needs [13] - The company is committed to expanding its market presence and improving its operational efficiency to enhance its core competitiveness and sustainable profitability [15][16]